News and Events
CBL -- Strategic Addition to Austin's Preferred Supplier Network
CBL and Austin offer natural and unnatural Fmoc amino acids, Resins, and loaded resins from USA inventory as well as unique synthesis capabilities to manufacture large peptides (30 – 150 amino acids). Over the past 20 years, CBL has developed a reputation as a premier manufacturer in the peptide industry. CBL is best known for having developed and commercialized the trityl resins. CBL’s expertise includes manufacture of peptide starting materials, GMP production of peptide intermediates, and API. CBL operates out of 10,000 square meter state-of-the-art laboratory and production space built for peptide synthesis located in Patras, Greece. In 2007, CBL opened a new building that houses GMP production facilities that includes brand-new large scale reactors designed for the facile scale-up of clinical drug programs. The facilities allow CBL to operate cost-effectively from the small to large scale. A 360° facility tour can be viewed at http://www.cblbiopharma.com/?page_id=18. In 2008, CBL opened a sales office and warehouse in Boulder, CO. A large inventory of natural and unnatural Fmoc amino acids, resins and loaded resins are stocked in the US to better serve CBL’s North American customers. CBL is not only a peptide manufacturing company, but is also recognized for peptide technology. On-going research programs to develop new methods and materials for peptides provide CBL with a wealth of publications and intellectual property. The company has discovered a number of solid phase resins and uniquely protected Fmoc amino acids. CBL holds intellectual property in peptide manufacturing strategies such as for the insulin-like peptides and others in the 30- to 150-amino acid range. CBL was founded by Prof. Dr. Kleomenis Barlos from the University of Patras. The company is under the leadership of Dr. Gary Erickson, the former Director of the Boulder Technology Center at Roche Colorado. CBL has awarded Austin representation of its products offerings and contract manufacturing capabilities specific to its unique technologies expertise. Austin continues to seek out and provide specialized manufacturing capabilities to its customers and welcomes CBL into its portfolio of niche products and services suppliers. We welcome your inquiries.
Consulting Serivces - Dr. Richard SpectorAustin is pleased to recommend Dr. Richard (Rich) Spector under our Consulting Services product. Rich has been employed in the pharmaceutical industry for over 25 years, responsible for Process Research and Development of APIs; spending most recently 19 years with Bristol-Myers Squibb as Director, Chemical Process Development. Responsibilities included global clinical product supply (API). Technical experience includes PR&D improvements at the pilot and commercial plant scales. Expertise includes route selection, cost analysis, and supply chain solutions addressing both commercially available and novel compounds. Rich routinely interacts with Regulatory Affairs and Quality Control personnel towards writing of the CMC section of a NDA; supporting his customers' needs in their interaction with the FDA. Budget creation or modification by analysis is another area of strength in which Rich can create a viable program. Experience includes commercialization of 9 products from development (preclinical / Phase I). Rich has been consulting since 2001; supporting both clinical supply needs and commercialization of product addressing all aspects of product quality, regulatory, and supply chain. Rich desires to take the products of small to medium-sized pharma companies with limited resources to commercialization or divestiture of their product; minimizing expenses while maximizing their ROI. You can contact Rich directly via his e-mail address at spectorr@comcast.net Flamma S.p.A. Facility is Classified FDA AcceptableWe are pleased to inform our customers that Flamma has achieved FDA acceptability of its facilities for API synthesis based upon inspection during Q4, 2009. Austin welcomes customer inquiries for this company; having been in existence since 1950. Please visit the Suppliers Page on this website to learn more about Flamma as well as link to their website. Infa SA is Part of Austin's Strategic and Preferred European Supplier NetworkInfa has grown over the past fifty years to include assets in Italy (Labochim and Sifavitor) and Spain (Derivados Quimicos S.A. and KyloLab). Austin Chemical Company, Inc. is responsible for U.S. sales of Infa's contract research and manufacturing capabilities. Three of Infa's four manufacturing sites are FDA acceptable, providing valuable assets for new chemical entities (intermediates and APIs) and toll manufacturing of late life cycle products. Technologies and capabilities address hazardous chemistries (Sodium metallic, Bromine, Chlorine, Cyanide, High Pressure large scale Hydrogenation) and are not bound by minimum volume quantities (total production capacity is exceeding 2,000 tons).
Infa strives to be a leading Preferred Supplier and Contract Manufacturer to the Pharmaceutical Industry for advanced intermediates and APIs. Infa Group regards Life Sciences and contract manufacturing product supply to Western Pharmaceutical companies as a viable and growing business in a long-term perspective thanks also to its highly experienced R&D Team of 25 people, the close cooperation with four European Universities and a strong regulatory and customer-oriented service team (approx. 50 US DMFs). Austin Chemical is very pleased to include Infa it its portfolio of suppliers, offering customers a viable option to address their production requirements as a toll or contract manufacturer.
Infa will be co-exhibiting with Austin Chemical at Informex 2010 in San Francisco (Booth 2318). Austin Chemical to Warehouse and Distribute Toray Chemical's DMSO
Toray Chemical USA has granted representative authority to Austin Chemical, to promote ultra-high purity Dimethyl Sulfoxide (DMSO) product sales in North America. Effective in December, 2009, Austin will regionally warehouse and distribute sample to drum quantities of Toray's DMSO product, to better serve clients in its core and non-core markets. If your finished product performance, consistency and process economics depend upon superior DMSO purity, call Austin Chemical. Contact Mr. David Lester - Vice President, Marketing, at 847-520-9600 x138 for product specifications, pricing, and availability. AllessaChemie Awards US Representation to Austin ChemicalAustin Chemical Company, Inc. is very pleased to include AllessaChemie GmbH in its portfolio of supplier representations. With more than 150 years of experience, AllessaChemie offers high quality fine chemicals and intermediates as well as specialty chemicals products including their branded Allessan® performance line. Within their three production facilities located in Germany (Rhine-Mein area), AllessaChemie offers a large number of reaction types and technologies which enable them to respond to their customers' requirements while maintaining the strictest quality requirements. Client industries include Pharma, Agro, Inks, Paper, Polymers, and Oilfield Chemicals.
Austin Chemical - Global Strategic Sourcing and Procurement ServicesChicago, IL. – Austin Chemical is promoting its global supply chain development, sourcing and delivery services to Pharmaceutical, Biotechnology, Food Ingredient and Fine Chemicals industries. |
|
|||||||||||||
Chicago Chemical Sales | Chicago Chemical Warehousing | Chicago Drug Development
Website Design Copyright © 2007 Website designed by Cherryoneweb.com
